RoC Monograph 13 recommends that antimony trioxide be listed as reasonably anticipated to be a human carcinogen.
Key numbers
PDF p.15: the recommendation rests on sufficient evidence in experimental animals and supporting mechanistic evidence. The monograph states that the human studies are inadequate to evaluate cancer from antimony trioxide or from antimony in general.
Methods (brief)
Hazard assessment monograph. It is not an occurrence survey.
Evidence fitness
Supports the listing recommendation and the statement that human evidence is inadequate. Does not support a quantitative oral or dermal risk number.
Limitations
The recommendation is for antimony trioxide, the compound tested by inhalation, not for every antimony species in a consumer article.
Related evidence
Update history
No substantive edit history is available in this build. The full commit record is available in git.